Healthcare
Healthcare Tools
Three tools prints
Thermo Fisher $44.56 billion and Danaher $24.57 billion are instruments, consumables, diagnostics, and biopharma services. IQVIA $16.31 billion is the CRO and commercial-data name. Agilent, Waters, and Charles River are on the roster and are not on this chart yet.
Thermo Fisher is a distribution and services pile
2025 segment revenues before eliminations: Lab Products and Biopharma Services $23.98 billion, Life Sciences Solutions $10.37 billion, Analytical Instruments $7.55 billion, Specialty Diagnostics $4.68 billion. Consolidated $44.56 billion after eliminations.
Danaher: diagnostics carries, life sciences stalled
2025: Diagnostics $9.94 billion, Life Sciences $7.33 billion, Biotechnology $7.29 billion. Life Sciences core sales declined 1.5 percent. Biotechnology core sales grew 6.5 percent.
